Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Kite To Acquire Tmunity Therapeutics To Pursue Next Generation Car T-Cell Therapy Advancements In Cancer
Acquiring Company
Kite
Acquired Company
Tmunity Therapeutics, Inc.
Santa MonicaPhiladelphiaManufacturingBiotechnologyTherapeuticsManufacturingBiotechnologyHealthcareTherapeuticsDescription
Kite, a Gilead Company (Nasdaq: GILD), and Tmunity Therapeutics (Tmunity), today announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies. The acquisition of Tmunity complements Kite’s existing in-house cell therapy research capabilities by adding additional pipeline assets, platform capabilities, and a strategic research and licensing agreement with the University of Pennsylvania (Penn).
Fundz sees it the moment Kite makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Tmunity Therapeutics, Inc.?
Tmunity Therapeutics, Inc. was acquired by Kite, based in Santa Monica. The deal was reported on December 20, 2022. Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. Kite is privately held and operates in Manufacturing.
When did Kite acquire Tmunity Therapeutics, Inc.?
Kite's acquisition of Tmunity Therapeutics, Inc. was reported on December 20, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Tmunity Therapeutics, Inc. do?
Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T-cell therapies, innovative manufacturing process and technologies. It is privately held, operating in Manufacturing, and is based in Philadelphia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.